We have given a prime minister who speaks: Amit Shah

Agencies

October 10, 2017

Amethi, Oct 10: BJP president Amit Shah today hit back at Congress vice president Rahul Gandhi for questioning what his party had done during its rule, saying it has "given a prime minister who speaks".

Shah also slammed Rahul for mocking the development in Gujarat by asking the Congress leader what three generations of his family had done for Amethi.

"He is mocking at the development in Gujarat. I want to ask 'Shahzade' of Congress as to what your three generations have given to Amethi," the BJP president said at a public meeting here.

"You sought account of our past three years but people of Amethi are taking account of works done here by your past three generations," he said.

On Rahul Gandhi's repeated poser as to what the BJP had done, Shah said, "We have given a prime minister who speaks."

"You have trusted a family for 60 years, now trust BJP and (Prime Minister Narendra) Modi and you will not feel betrayed," Shah told the gathering in the presence of Union minister Smriti Irani and chief minister Yogi Adityanath.

Shah said there were two models of development here -- a 'Nehru-Gandhi model' and the other the 'Modi model'.

"Congress ruled the country for 70 years. I want to ask you that you have been MP here for a long time but why there is no collector's office, TB hospital and Akashwani's FM here. Erosion of land due to Gomti river has not been stopped," Shah said.

Naming the schemes launched by the Narendra Modi government, he said that 106 projects were launched in the past three years.

"For the first time in 35-40 years, I am seeing that the winning candidate remains missing from his constituency and a defeated candidate is giving time for the people," Shah said, hailing the work being done in the area by Irani.

Irani was defeated by Rahul in the 2014 Lok Sabha polls.

The BJP chief said that Amethi is known all over the world as a Nehru-Gandhi family bastion, but there has been no development.

"Chief Minister Yogi Adityanath and Prime Minister Narendra Modi will develop UP," he asserted.

Taking a swipe at Rahul, Shah said, "Rahul baba cannot see development as he sports Italian spectacles."

Comments

Sir Amit shah Ji. We dont want PM who only speaks . We want Pm who only works. So if you have power then kindly replace.

not speak Bol Bachhan

He speaks only lies ..... Fenku

He is right. Feku only speaks. No development all.

Add new comment

Coastaldigest.com reserves the right to delete or block any comments.
Coastaldigset.com is not responsible for its readers’ comments.
Comments that are abusive, incendiary or irrelevant are strictly prohibited.
Please use a genuine email ID and provide your name to avoid reject.

Over 1 million patients recovered from covid-19 so far in India

Agencies

July 30,2020

New Delhi, Jul 30: Even as COVID-19 cases continue to surge in various parts of India, more than 1 million people have recovered and discharged till now, informed Rajesh Bhushan, Secretary, Ministry of Health, here on Thursday.

"More than 1 million people have recovered from COVID-19 in the country. This landmark recovery has been achieved because of the selfless work and dedication of our doctors, nurses and frontline workers," Bhushan said at a press conference.

Giving the number of cured persons, Bhushan said, "More than 1,020,000 patients have recovered. They have been discharged. It is a great achievement."

He said, "The recovery rate has shown positive trends. It was 7.85 per cent in April and today it is 64.4 per cent, which is another heartening news which tells us that whatever battle is put by the Union government in collaboration with state governments is showing results."

"Sixteen states of the country have a recovery rate that is more than the national average. Of these, Delhi has a recovery rate of 88 per cent, Ladakh 80 per cent, Haryana 78 per cent, Assam 76 per cent, Telangana 74 per cent, Tamil Nadu & Gujarat 73 per cent, Rajasthan 70 per cent, Madhya Pradesh 69 per cent and Goa 68 per cent," Bhushan said.

He said effective clinical management lead to a decrease in case fatality rate. In June it was 3.33 per cent and now 2.21 per cent.

Bhushan said the case fatality rate in India today is 2.21 per cent and it's among the lowest in the world. Twenty-four states and Union Territories have lesser fatality rate than that of the country.

Herd immunity in a country of the size and population of India can not be a strategic option. It can only be achieved through immunisation.

"Over 18,190,000 tests have been conducted in the country including RT-PCR and rapid antigen tests. There has been a week-on-week increase in average tests per day. India is conducting 324 test per 10 lakhs population per day," Bhushan said.

He added, three vaccine candidates, are in phase 3 clinical trial. These three are in the US, UK and China. In India, two indigenously developed vaccine candidates are in phase I and II of clinical trials.

Trial of the first vaccine involves 1,150 subjects at eight sites, second on 1,000 subjects at five sites.

Comments

Add new comment

Coastaldigest.com reserves the right to delete or block any comments.
Coastaldigset.com is not responsible for its readers’ comments.
Comments that are abusive, incendiary or irrelevant are strictly prohibited.
Please use a genuine email ID and provide your name to avoid reject.

Sambit Patra hospitalised after showing COVID-19 symptoms

News Network

May 28,2020

New Delhi, May 28: BJP national spokesperson Sambit Patra has been admitted to a private hospital in Gurgaon after he showed symptoms of COVID-19, sources said.

He is admitted to the Medanta hospital in Gurgaon, hospital sources said on Thursday.

The BJP leader has shown symptoms of COVID-19, a source said.

Patra is one of the most visible BJP faces on news channels.

He is also very active on social media and posted several tweets on Thursday as well.

Comments

Add new comment

Coastaldigest.com reserves the right to delete or block any comments.
Coastaldigset.com is not responsible for its readers’ comments.
Comments that are abusive, incendiary or irrelevant are strictly prohibited.
Please use a genuine email ID and provide your name to avoid reject.

First patient to receive plasma therapy in UP dies of heart attack

News Network

May 9,2020

Lucknow, May 9: The first patient to receive plasma therapy as an experimental treatment for coronavirus infection in Uttar Pradesh died following a heart attack on Saturday.

The patient, a 58-year-old doctor, was admitted at the King George’s Medical University (KGMU) here.

The doctor, who was on ventilator since the last 14 days, died on Saturday evening following a heart attack, KGMU Vice-Chancellor M L B Bhatt said.

Since he had high blood pressure and diabetes, he was under the continuous observation of doctors in the isolation ward, Bhatt said.

“The patient was in a stable condition. His lungs had improved, but he later developed urinary tract infection. Two reports of his samples came out as negative (for COVID-19) today,” the vice-chancellor said.

“He, however, suffered a heart attack around 5 pm. Despite all efforts, he could not be saved,” he said.

The doctor from Orai in Uttar Pradesh was administered plasma therapy at the state-run KGMU on April 26. He was administered the plasma donated by a doctor from Canada who was the first COVID-19 patient admitted at the hospital and later recovered.

Tulika Chandra of Blood Transfusion Department, KGMU said, "When the patient was given plasma therapy, his condition was very bad. His lungs, however, improved. But as he was an old patient with diabetes, he was kept on the ventilator.”

Convalescent Plasma Therapy is an experimental procedure for treating COVID-19 patients. In this treatment, plasma, a blood component, from a cured patient is transfused to a critically ill coronavirus patient.

The blood of a person who has recovered from COVID-19 develops antibodies to fight the virus. This therapy uses the antibodies from the blood of a cured patient to treat another critical patient.

The Union health ministry, however, had advised against considering the therapy to be a regular treatment for coronavirus, adding it should be used for research and trial purposes till there is a piece of robust scientific evidence to support its efficacy.

Comments